FIELD: chemistry.
SUBSTANCE: invention relates to a novel purified compound PM 181104 of formula I
(with molecular weight 1514 and molecular formula C69H66N18O13S5), pharmaceutically acceptable salts thereof, methods for synthesis via fermentation of a microorganism of the type Kocuria (ZMA B-1 / MTCC 5269), as well as pharmaceutical compositions.
EFFECT: high efficiency of using the composition to produce a medicinal agent for treating bacterial infections.
20 cl, 4 dwg, 4 tbl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBIOTIC COMPOUNDS | 2010 |
|
RU2536587C2 |
| VANCORESMYCIN (VARIANTS), ITS APPLICATION, STRAIN AMYCOLATOPSIS OF SPECIES HIL-006734 FOR ITS PREPARING | 1999 |
|
RU2228337C2 |
| 5-HYDROXYMETHYLOXAZOLIN-2-ONE DERIVATIVES FOR TREATING BACTERIAL INTESTINAL DISEASES | 2009 |
|
RU2527769C2 |
| DRUG FOR TREATMENT OF DISEASES CAUSED BY BACTERIA | 2020 |
|
RU2754610C1 |
| AMYCOMYCIN, METHOD FOR ITS PREPARING AND ITS APPLYING AS PHARMACEUTICAL AGENT | 2000 |
|
RU2261916C2 |
| SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[6-FLUORO-5-[2-(1-HYDROXY-1-METHYL-ETHYL) PYRIMIDIN-5-YL]-7-(TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL] UREA | 2012 |
|
RU2625305C2 |
| PHOTOSTABLE PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF FOCI OF BACTERIAL DISEASE | 2017 |
|
RU2662082C2 |
| NOVEL ANTIBACTERIAL MEDICATIONS FOR TREATMENT OF GRAM-POSITIVE INFECTIONS | 2009 |
|
RU2512396C2 |
| AMIDE DERIVATIVE OF SALICYLIC ACID, HAVING ANTIBACTERIAL, ANTIFUNGAL AND ANTILYSOZYMIC ACTIVITY | 2012 |
|
RU2504536C1 |
| ANTIMICROBIAL-ANTIBIOFILM COMPOSITIONS AND METHODS OF USE THEREOF | 2014 |
|
RU2662764C2 |
